Close Menu

NEW YORK (GenomeWeb) – Premaitha Health said today that the Brazilian Health Regulatory Agency (ANVISA) has approved its Iona noninvasive prenatal test as an in vitro diagnostic.

Last September, the agency had already granted the Iona test Brazilian Good Manufacturing Practice (B-GMP) approval, a requirement to register it with ANVISA.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.